Canada Pension Plan Investment Board Arvinas, Inc. Transaction History

Canada Pension Plan Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$60.45 - $84.26 $1.99 Million - $2.78 Million	-33,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$58.19 - $91.37 $424,787 - $667,001	-7,300 Reduced 18.11%	33,000 $2.18 Million
Q4 2020 Feb 17, 2021	BUY	$20.19 - $84.93 $813,657 - $3.42 Million	40,300 New	40,300 $3.42 Million
Q1 2020 May 13, 2020	SELL	$33.0 - $54.5 $5.66 Million - $9.35 Million	-171,500 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $2.64 Million - $7.61 Million	171,500 New	171,500 $7.05 Million

224

68.7M

166K

31.3K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.3B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.